Patents by Inventor Jagdev Singh Jaryal

Jagdev Singh Jaryal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for the preparation of dasatinib and its intermediates
    Patent number: 9365526
    Abstract: The present invention relates to processes for the preparation of dasatinib and its intermediates.
    Type: Grant
    Filed: December 31, 2013
    Date of Patent: June 14, 2016
    Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Jagdev Singh Jaryal, Munish Kapoor, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • PROCESS FOR THE PREPARATION OF DASATINIB AND ITS INTERMEDIATES
    Publication number: 20150336913
    Abstract: The present invention relates to processes for the preparation of dasatinib and its intermediates.
    Type: Application
    Filed: December 31, 2013
    Publication date: November 26, 2015
    Inventors: Jagdev Singh JARYAL, Munish KAPOOR, Swargam SATHYANARAYANA, Rajesh Kumar THAPER, Mohan PRASAD
  • Sorafenib dimethyl sulphoxide solvate
    Patent number: 8618305
    Abstract: The present invention provides dimethyl sulphoxide solvate of 4-(4-{3-[4-chloro-3 -(trifluoromethyl)phenyl]ureido}phenoxy)-N2-methylpyridine-2-carboxamide, process for its preparation, pharmaceutical composition comprising it and its use for the treatment of cancer. The present invention also provides a novel HPLC method for the identification, quantification and isolation of related substances of sorafenib.
    Type: Grant
    Filed: January 28, 2011
    Date of Patent: December 31, 2013
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Jagdev Singh Jaryal, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad, Sachin Deorao Zade, Ajay Shankar Singh
  • Polymorphs of sorafenib acid addition salts
    Patent number: 8614329
    Abstract: The present invention provides amorphous and crystalline forms of acid addition salts of sorafenib, pharmaceutical compositions comprising them, and their use for the treatment of cancer. The present invention also provides processes for the preparation of acid addition salts of sorafenib.
    Type: Grant
    Filed: June 7, 2013
    Date of Patent: December 24, 2013
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Jagdev Singh Jaryal, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • Process for the preparation of sorafenib tosylate
    Patent number: 8609854
    Abstract: The present invention provides a process for the preparation of sorafenib tosylate, comprising contacting sorafenib free base with p-toluenesulphonic acid in water.
    Type: Grant
    Filed: September 24, 2010
    Date of Patent: December 17, 2013
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Jagdev Singh Jaryal, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • Polymorphs of sorafenib acid addition salts
    Patent number: 8604208
    Abstract: The present invention provides amorphous and crystalline forms of acid addition salts of sorafenib, pharmaceutical compositions comprising them and their use for the treatment of cancer. The present invention also provides processes for the preparation of acid addition salts of sorafenib.
    Type: Grant
    Filed: September 24, 2010
    Date of Patent: December 10, 2013
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Jagdev Singh Jaryal, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • POLYMORPHS OF SORAFENIB ACID ADDITION SALTS
    Publication number: 20130274478
    Abstract: The present invention provides amorphous and crystalline forms of acid addition salts of sorafenib, pharmaceutical compositions comprising them, and their use for the treatment of cancer. The present invention also provides processes for the preparation of acid addition salts of sorafenib.
    Type: Application
    Filed: June 7, 2013
    Publication date: October 17, 2013
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Jagdev Singh JARYAL, Swargam SATHYANARAYANA, Rajesh Kumar THAPER, Mohan PRASAD
  • Sorafenib ethylsulfonate salt, process for preparation and use
    Patent number: 8552197
    Abstract: The present invention provides sorafenib ethane sulphonate, process for its preparation, pharmaceutical composition comprising sorafenib ethane sulphonate and its use for the treatment of cancer. Formula (III).
    Type: Grant
    Filed: November 12, 2010
    Date of Patent: October 8, 2013
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Jagdev Singh Jaryal, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • SORAFENIB DIMETHYL SULPHOXIDE SOLVATE
    Publication number: 20130210865
    Abstract: The present invention provides dimethyl sulphoxide solvate of 4-(4-{3-[4-chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N2-methylpyridine-2-carboxamide, process for its preparation, pharmaceutical composition comprising it and its use for the treatment of cancer. The present invention also provides a novel HPLC method for the identification, quantification and isolation of related substances of sorafenib.
    Type: Application
    Filed: January 28, 2011
    Publication date: August 15, 2013
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Jagdev Singh Jaryal, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad, Sachin Deorao Zade, Ajay Shankar Sinch
  • PROCESS FOR THE PREPARATION OF SORAFENIB TOSYLATE
    Publication number: 20130005980
    Abstract: The present invention provides a process for the preparation of sorafenib tosylate, comprising contacting sorafenib free base with p-toluenesulphonic acid in water.
    Type: Application
    Filed: September 24, 2010
    Publication date: January 3, 2013
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Jagdev Singh Jaryal, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • SORAFENIB ETHYLSULFONATE SALT, PROCESS FOR PREPARATION AND USE
    Publication number: 20130005777
    Abstract: The present invention provides sorafenib ethane sulphonate, process for its preparation, pharmaceutical composition comprising sorafenib ethane sulphonate and its use for the treatment of cancer. Formula (III).
    Type: Application
    Filed: November 12, 2010
    Publication date: January 3, 2013
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Jagdev Singh Jaryal, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • POLYMORPHS OF SORAFENIB ACID ADDITION SALTS
    Publication number: 20120264789
    Abstract: The present invention provides amorphous and crystalline forms of acid addition salts of sorafenib, pharmaceutical compositions comprising them and their use for the treatment of cancer. The present invention also provides processes for the preparation of acid addition salts of sorafenib.
    Type: Application
    Filed: September 24, 2010
    Publication date: October 18, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Jagdev Singh Jaryal, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad